These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20598547)

  • 1. Anthropometric indexes, insulin resistance, and serum leptin and lipid levels in women with cryptogenic epilepsy receiving topiramate treatment.
    Genc BO; Dogan EA; Dogan U; Genc E
    J Clin Neurosci; 2010 Oct; 17(10):1256-9. PubMed ID: 20598547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of body weight and serum leptin levels in patients treated with topiramate.
    Theisen FM; Beyenburg S; Gebhardt S; Kluge M; Blum WF; Remschmidt H; Elger CE; Hebebrand J
    Clin Neuropharmacol; 2008; 31(4):226-30. PubMed ID: 18670246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment.
    Okuyaz C; Kursel O; Komur M; Tamer L
    Pediatr Neurol; 2012 Dec; 47(6):423-6. PubMed ID: 23127262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topiramate on weight and metabolism in children with epilepsy.
    Li HF; Zou Y; Xia ZZ; Gao F; Feng JH; Yang CW
    Acta Paediatr; 2009 Sep; 98(9):1521-5. PubMed ID: 19508301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy.
    Sonmez FM; Zaman D; Aksoy A; Deger O; Aliyazicioglu R; Karaguzel G; Fazlioglu K
    Seizure; 2013 Dec; 22(10):856-61. PubMed ID: 23937963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy.
    Ozcelik AA; Serdaroglu A; Bideci A; Arhan E; Soysal Ş; Demir E; Gücüyener K
    Pediatr Neurol; 2014 Aug; 51(2):220-4. PubMed ID: 25079570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between circulating leptin and insulin resistance, the lipid profile, and metabolic risk factors in North Indian adult women.
    Gupta A; Gupta V; Agrawal S; Natu SM; Agrawal CG; Negi MP; Tiwari S
    Biosci Trends; 2010 Dec; 4(6):325-32. PubMed ID: 21248431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
    Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
    Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight reducing and metabolic effects of topiramate in patients with migraine--an observational study.
    Schütt M; Brinkhoff J; Drenckhan M; Lehnert H; Sommer C
    Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):449-52. PubMed ID: 20200812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of weight loss in adults with topiramate-treated epilepsy.
    Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
    Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum leptin and insulin resistance in obesity and effects of sibutramine on them].
    Wu J; Lei MX; Chen HL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):605-7. PubMed ID: 15804071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
    Hamed SA; Fida NM; Hamed EA
    Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of carbamazepine treatment on serum leptin levels.
    Uludag IF; Kulu U; Sener U; Kose S; Zorlu Y
    Epilepsy Res; 2009 Sep; 86(1):48-53. PubMed ID: 19473818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
    Kim JY; Lee HW
    Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting serum leptin level correlates with mid-arm fat area in peritoneal dialysis patients.
    Fang TC; Lee CJ; Wang CH; Liou HH; Hsu BG
    Ther Apher Dial; 2010 Dec; 14(6):583-8. PubMed ID: 21118367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation.
    Mikkonen K; Knip M; Pakarinen AJ; Lanning P; Isojärvi JI; Vainionpää LK
    Epilepsia; 2005 Jul; 46(7):1114-20. PubMed ID: 16026564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia.
    Mendoza-Núñez VM; García-Sánchez A; Sánchez-Rodríguez M; Galván-Duarte RE; Fonseca-Yerena ME
    Obes Res; 2002 Apr; 10(4):253-9. PubMed ID: 11943833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.